← All companies
PHGE
BiomX Inc.
$0.19
-0.00 -1.16%
Key statistics
from XBRL data in SEC filingsMarket cap
$1.90M
Revenue (TTM)
—
Net income (TTM)
-$47.7M
EPS (TTM)
$23.30
P/E ratio
0.0
Dividend yield
—
Free cash flow
-$26.4M
Cash
$1.17M
Total assets
$3.25M
Gross margin
—
52-week range
$0.17 – $13.70
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Entered a material agreement; Unregistered sale of equity
Jul 28, 2026
8-K
Other events
Jul 10, 2026
8-K
Changed accountants
Jul 2, 2026
8-K
Shareholder vote results
Jun 26, 2026
8-K
Regulation FD disclosure
Jun 18, 2026
8-K
Delisting notice or listing-rule failure; Regulation FD disclosure
Jun 12, 2026
8-K/A
AMENDMENT NO. 1 TO FORM 8-K
Jun 12, 2026
8-K
Unregistered sale of equity
Jun 5, 2026
8-K
Director or officer change
May 28, 2026
10-Q
Quarter ended 2026-03-31
May 20, 2026
8-K
Other events
May 5, 2026
10-K/A
Fiscal year ended 2025-12-31
Apr 30, 2026
8-K
Regulation FD disclosure; Other events
Apr 16, 2026
8-K
Entered a material agreement; Completed an acquisition or disposition; Unregistered sale of equity; Regulation FD disclosure
Apr 13, 2026
8-K
Shareholder vote results
Apr 10, 2026
8-K
Entered a material agreement; Completed an acquisition or disposition; Unregistered sale of equity; Regulation FD disclosure
Apr 10, 2026
8-K
Entered a material agreement
Apr 1, 2026
8-K
Delisting notice or listing-rule failure; Other events
Mar 27, 2026
8-K
Entered a material agreement; Regulation FD disclosure
Mar 19, 2026
8-K
Shareholder vote results
Mar 11, 2026
8-K
Director or officer change
Mar 6, 2026
8-K
Director or officer change; Other events
Mar 2, 2026
8-K
Director or officer change
Feb 25, 2026
10-K
Fiscal year ended 2025-12-31
Feb 19, 2026
8-K
Director or officer change
Feb 13, 2026
8-K
Completed an acquisition or disposition; Director or officer change
Feb 10, 2026
8-K
Modified rights of security holders; Director or officer change; Amended charter or bylaws
Jan 14, 2026
8-K
Terminated a material agreement
Jan 7, 2026
8-K
Entered a material agreement; Unregistered sale of equity
Dec 29, 2025
8-K
Other events
Dec 11, 2025
8-K
Other events
Dec 8, 2025
8-K
Other events
Nov 25, 2025
8-K
Modified rights of security holders; Amended charter or bylaws
Nov 17, 2025
10-Q
Quarter ended 2025-09-30
Nov 12, 2025
8-K
Results of operations (earnings release)
Nov 12, 2025
8-K
Shareholder vote results
Oct 17, 2025
8-K
Other events
Oct 17, 2025
8-K
Other events
Aug 19, 2025
10-Q
Quarter ended 2025-06-30
Aug 13, 2025
8-K
Results of operations (earnings release)
Aug 13, 2025